Cargando…
Canagliflozin-associated severe hyponatremia: a rare and potentially adverse effect?
SUMMARY: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) induce osmotic diuresis by inhibiting the proximal renal tubular reabsorption of the filtered glucose load, which in turn can occasionally lead to severe dehydration and hypotension amidst other adverse effects. We present a case of a 49-ye...
Autores principales: | Dhanasekaran, Maheswaran, Narayanan, Siddharth, Mastoris, Ioannis, Mehta, Suchita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002205/ https://www.ncbi.nlm.nih.gov/pubmed/35352682 http://dx.doi.org/10.1530/EDM-21-0035 |
Ejemplares similares
-
Severe hypercalcemia and hypernatremia in a patient treated with canagliflozin
por: Kaur, Arshpreet, et al.
Publicado: (2015) -
SUN-699 Canagliflozin Induced Severe Hyponatremia- a Rare Life Threatening and Poorly Understood Complication- a Case Report
por: Dhanasekaran, Maheswaran, et al.
Publicado: (2020) -
Severe symptomatic hyponatremia associated with the use of polyethylene glycol-based bowel preparation
por: Samad, Navira, et al.
Publicado: (2017) -
Autoimmune hypothyroidism and trastuzumab therapy: a rare association
por: Lopes, Valentim, et al.
Publicado: (2023) -
Symptomatic hypophosphataemia after intravenous iron therapy: an underrated adverse reaction
por: Ifie, Eseoghene, et al.
Publicado: (2019)